a randomised trial but an observational prospective study and therefore was not analysed according to intention to treat. All women with symptomatic pelvic organ prolapse (POP) referred to a specialist urogynaecology clinic were offered a choice of pessary or surgery as their first-line treatment.
. Our study was not designed to enable interpretation of symptoms on an individual basis; perhaps this is best answered in a qualitative study. Also, the study was designed to assess the cost effectiveness of a primary treatment strategy.
To our knowledge, this is the first prospective study to evaluate comparative outcomes of vaginal pessaries and surgery using the validated ICIQ-VS and ICIQ-UI (SF) questionnaires at 1 year. At this time, the study provides the best available evidence base by which to counsel women.
